Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Aprindine

Home DrugsAprindine

Experimental

Small Molecule

Aprindine

Unknown Manufacturer

Aprindine is a cardiac depressant used in arrhythmias.

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Overview

Aprindine is a cardiac depressant used in arrhythmias.

Indications

可用于室性及房性早搏、阵发性室上性心动过速、房颤等，对各种快速型心律失常有较好疗效。

Technical identifiers

Chemical Formula: C₂₂H₃₀N₂
CAS Number: 37640-71-4
UNII ID: 5Y48085P9Q

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Aprindine hydrochloride medicinal composition and medicinal use thereof
Applicant: XU YUXIANPriority: 2016
CN
METHOD FOR INCREASING THE REPLICATION CAPACITY OF AN INFLUENZA VIRUS IN CULTURED CELLS
Applicant: LOTTEAU VINCENTPriority: 2011
US